B
Bicycle Therapeutics plc (BCYC)
NMS – Real Time Price. Currency in USD
4.31
-0.19 (-4.22%)
At close: Mar 27, 2026, 4:00 PM EDT
4.33
+0.02 (0.46%)
After-hours: Mar 27, 2026, 7:29 PM EDT
Get all premium features to the best stock analysis tool
NMS – Real Time Price. Currency in USD
4.31
-0.19 (-4.22%)
At close: Mar 27, 2026, 4:00 PM EDT
4.33
+0.02 (0.46%)
After-hours: Mar 27, 2026, 7:29 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 11.98 | 6.05 | 10 | |
| Quick ratio | 11.98 | 5.63 | 10 | |
| Debt to Equity | 0.03 | 0.30 | 9.0 | |
| Debt to Assets | 0.02 | 1.04 | 9.0 | |
| Interest coverage | -546.00 | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 14M | 27M | 35M | 73M | 73M |
| Gross Profit | 11M | 21M | 28M | 66M | 66M |
| Operating Income | -138M | -216M | -252M | -283M | -284M |
| Net Income | -113M | -181M | -169M | -219M | -220M |
| EBITDA | -135M | -209M | -245M | -277M | -277M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -18.67 | 22.22 | 5.5 |
| Next quarter | 134.72 | 46.39 | 10 |
| Current year | -54.71 | 23.89 | 5.5 |
| Next year | -6.06 | 4.97 | 2.5 |
| Weighted average score | 5.9 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 310.66 | 65.73 | 65.88 | 72.41 | 10 |
| Y/Y | 1203.5 | 60.83 | 61.33 | -115.42 | 7.8 |
| 3y average | 74.61 | -27.99 | 0.09 | -57.69 | 3.5 |
| 5y average | 51.83 | -36.5 | -8.47 | -137.06 | 3.3 |
| Weighted average score | 6.2 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $628.7M significantly exceed its total debt $17.5M, ensuring strong financial flexibility
Total current assets $682.9M exceed Total current liabilities $57.0M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-546.0x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$19.7M limits the company's ability to reinvest or pay down debt